Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP).
Dermatofibrosarcoma protuberans (DP), an infiltrative skin tumour of intermediate malignancy, presents specific cytogenetic features such as reciprocal translocations t(17;22)(q22;q13.1) or supernumerary ring chromosomes derived from t(17;22). We have previously shown that both rings and translocated chromosomes derived from t(17;22) presented the same molecular rearrangement with fusion of the COL1A1 gene on chromosome 17 to the PDGFB gene on chromosome 22. To study the structure and function of the COL1A1-PDGFB chimeric protein, we used a tumour-derived chimeric COL1A1-PDGFB cDNA to perform stable and transient transfections in the Chinese hamster lung fibroblastic cell line PS200 and the human epithelial cell line HEK293. We demonstrated that the stably transfected clones that expressed the COL1A1-PDGFB chimeric protein became growth factors independent and tumorigenic in nude mice. In addition, COL1A1-PDGFB transfected cell supernatants significantly stimulated fibroblastic cell growth, through the activation of the PDGFB receptor pathway. By using anti-PDGFB and specific anti-COL1A1-PDGFB antibodies, we showed that, similar to PDGFB, the COL1A1-PDGFB chimeric proteins are processed in transfected cells into mature PDGFB dimers. These results strongly suggest that the COL1A1-PDGFB chimeric gene expression associated with DP, induces tumours formation through production of mature PDGFB, in an autocrine or paracrine way. Strikingly, mutagenesis experiments indicated that uncleaved COL1A1-PDGFB forms are mitogenic and therefore could contribute, as well as mature PDGFB, to the establishment of a transformed phenotype.
Simon
M P
MP
Institute of Signalling, Developmental Biology and Cancer Research, CNRS UMR 6543, Centre Antoine-Lacassagne, 06189 Nice cedex 2, France.
Navarro
M
M
Roux
D
D
Pouysségur
J
J
D000818:Animals; D015197:Carcinogenicity Tests; D002886:Chromosomes, Human, Pair 17; D002892:Chromosomes, Human, Pair 22; D003094:Collagen / Q000235:genetics*; D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D006224:Cricetinae; D018223:Dermatofibrosarcoma / Q000235:genetics*; D005347:Fibroblasts; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D008934:Mitogens / Q000378:metabolism; D009154:Mutation; D015514:Oncogene Proteins, Fusion; D020574:Proto-Oncogene Proteins c-sis / Q000235:genetics*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism; D012878:Skin Neoplasms / Q000235:genetics*; D014162:Transfection; D014178:Translocation, Genetic
D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D008934:Mitogens; D015514:Oncogene Proteins, Fusion; D020574:Proto-Oncogene Proteins c-sis; D003094:Collagen; D020797:Receptor, Platelet-Derived Growth Factor beta